Search Results

There are 3181 results for: content related to: An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy

  1. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

    Annals of Neurology

    Volume 65, Issue 2, February 2009, Pages: 140–150, Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Motoko Takamori, Mizuki Ito, Tomohiko Nakamura, Koji Matsuo, Shinichi Yamada, Yumiko Oki, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Naoki Atsuta, Hirohisa Watanabe, Yasushi Fujimoto, Tsutomu Nakashima, Fumiaki Tanaka, Manabu Doyu and Gen Sobue

    Version of Record online : 3 MAR 2009, DOI: 10.1002/ana.21540

  2. A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate

    Journal of Cutaneous Pathology

    Volume 36, Issue 12, December 2009, Pages: 1299–1302, T. Watanabe, N. Yamada, Y. Yoshida and O. Yamamoto

    Version of Record online : 13 MAR 2009, DOI: 10.1111/j.1600-0560.2009.01270.x

  3. You have free access to this content
    A randomised controlled trial comparing GnRH antagonist Cetrorelix with GnRH agonist Leuprorelin for endometrial thinning prior to transcervical resection of endometrium

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 115, Issue 10, September 2008, Pages: 1214–1224, K Bhatia, Y Doonan, A Giannakou and B Bentick

    Version of Record online : 11 AUG 2008, DOI: 10.1111/j.1471-0528.2008.01837.x

    Corrected by:

    Corrigendum

    Vol. 115, Issue 13, 1723, Version of Record online: 13 NOV 2008

  4. You have full text access to this Open Access content
    Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone–releasing hormone agonist

    Cancer Science

    Volume 97, Issue 6, June 2006, Pages: 459–467, Mahmoud M. Said, Naomi Hokaiwado, Mingxi Tang, Kumiko Ogawa, Shugo Suzuki, Hala M. Ghanem, Amr Y. Esmat, Makoto Asamoto, Fawzia M. Refaie and Tomoyuki Shirai

    Version of Record online : 26 MAY 2006, DOI: 10.1111/j.1349-7006.2006.00213.x

  5. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)

    Neuropathology

    Volume 29, Issue 4, August 2009, Pages: 509–516, Keisuke Suzuki, Masahisa Kastuno, Haruhiko Banno and Gen Sobue

    Version of Record online : 22 MAY 2009, DOI: 10.1111/j.1440-1789.2009.01013.x

  6. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: A pathogenic marker

    Annals of Neurology

    Volume 59, Issue 3, March 2006, Pages: 520–526, Haruhiko Banno, Hiroaki Adachi, Masahisa Katsuno, Keisuke Suzuki, Naoki Atsuta, Hirohisa Watanabe, Fumiaki Tanaka, Manabu Doyu and Gen Sobue

    Version of Record online : 15 DEC 2005, DOI: 10.1002/ana.20735

  7. You have free access to this content
    Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1200–1208, Santiago Vilar González and Xavier Maldonado Pijuan

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09827.x

  8. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy

    Neuropathology and Applied Neurobiology

    Volume 33, Issue 2, April 2007, Pages: 135–151, H. Adachi, M. Waza, M. Katsuno, F. Tanaka, M. Doyu and G. Sobue

    Version of Record online : 8 MAR 2007, DOI: 10.1111/j.1365-2990.2007.00830.x

  9. You have free access to this content
    Protecting spermatogonia from apoptosis induced by doxorubicin using the luteinizing hormone-releasing hormone analog leuprorelin

    International Journal of Urology

    Volume 10, Issue 2, February 2003, Pages: 72–77, FUMIYASU ENDO, FUMIO MANABE, HITOSHI TAKESHIMA and HIDEYUKI AKAZA

    Version of Record online : 20 FEB 2003, DOI: 10.1046/j.1442-2042.2003.00572.x

  10. Leuprorelin acetate granulomas: case reports and review of the literature

    British Journal of Dermatology

    Volume 152, Issue 5, May 2005, Pages: 1045–1047, K. Yasukawa, D. Sawamura, H. Sugawara and N. Kato

    Version of Record online : 10 MAR 2005, DOI: 10.1111/j.1365-2133.2005.06341.x

  11. Granuloma caused by subcutaneous injection of leuprorelin acetate product: Case report and histopathological findings

    The Journal of Dermatology

    Volume 33, Issue 10, October 2006, Pages: 719–721, Takeshi OUCHI, Tetushi KOYAMA, Naho MIYATA and Makoto SUGIURA

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1346-8138.2006.00167.x

  12. Mechanism-specific treatment of a polyglutamine disorder

    Clinical Genetics

    Volume 64, Issue 5, November 2003, Pages: 379–380, J Van Raamsdonk

    Version of Record online : 21 OCT 2003, DOI: 10.1034/j.1399-0004.2003.t01-1-00165.x

  13. Granulomas induced by subcutaneous injection of a luteinizing hormone-releasing hormone analog: a case report and review of the literature

    Journal of Cutaneous Pathology

    Volume 37, Issue 10, October 2010, Pages: 1116–1118, Tessin Watanabe, Nanako Yamada, Yuichi Yoshida and Osamu Yamamoto

    Version of Record online : 26 OCT 2009, DOI: 10.1111/j.1600-0560.2009.01456.x

  14. Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty

    Journal of Paediatrics and Child Health

    Volume 48, Issue 3, March 2012, Pages: E136–E139, Stephanie R Johnson, Richard C Nolan, Maree T Grant, Glynis J Price, Aris Siafarikas, Lewis Bint and Catherine SY Choong

    Version of Record online : 12 MAY 2011, DOI: 10.1111/j.1440-1754.2011.02083.x

  15. Granulomas induced by subcutaneous injection of leuprorelin acetate

    The Journal of Dermatology

    Volume 33, Issue 1, January 2006, Pages: 43–45, Ryoko SAKAMOTO, Yuko HIGASHI, Kentaro MERA, Takuro KANEKURA and Tamotsu KANZAKI

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1346-8138.2006.00008.x

  16. You have free access to this content
    Protecting spermatogenesis from damage induced by doxorubicin using the luteinizing hormone-releasing hormone agonist leuprorelin

    Cancer

    Volume 79, Issue 5, 1 March 1997, Pages: 1014–1021, Fumio Manabe, Hitoshi Takeshima and Hideyuki Akaza

    Version of Record online : 28 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970301)79:5<1014::AID-CNCR19>3.0.CO;2-4

  17. You have free access to this content
    A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 107, Issue 3, March 2000, Pages: 323–328, Andrew D. Weeks, Sean R. G. Duffy and James J. Walker

    Version of Record online : 12 AUG 2005, DOI: 10.1111/j.1471-0528.2000.tb13226.x

  18. You have full text access to this OnlineOpen article
    Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer

    Respirology Case Reports

    Volume 4, Issue 2, April 2016, Hsern Ern Tan and Fiona Lake

    Version of Record online : 31 MAR 2016, DOI: 10.1002/rcr2.146

  19. Leuprorelin acetate blood levels and dialysance after the administration of sustained-release leuprorelin acetate in a dialysis case complicated by prostate cancer

    The Prostate

    Volume 34, Issue 3, 15 February 1998, Pages: 191–194, Kazuhisa Saruki, Tetsuo Sekihara, Masamichi Mashimo, Hidenori Matsuo and Hiroyuki Sekiguchi

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(19980215)34:3<191::AID-PROS6>3.0.CO;2-L

  20. You have free access to this content
    Progestogens or progestogen-releasing intrauterine systems for uterine fibroids

    Intervention Review

    The Cochrane Library

    Ussanee S Sangkomkamhang, Pisake Lumbiganon, Malinee Laopaiboon and Ben Willem J Mol

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD008994.pub2